Icosapent ethyl
Indication
Reducing the risk of cardiovascular events in people with raised triglycerides - NICE TA805
Brand:
Nice TA:
805
Commissioning responsibility:
CCG
PbR excluded:
No
Background
1.1 Icosapent ethyl is recommended as an option for reducing the risk of cardiovascular events in adults. It is recommended if they have a high risk of cardiovascular events and raised fasting triglycerides (1.7 mmol/litre or above) and are taking statins, but only if they have:
-
established cardiovascular disease (secondary prevention), defined as a history of any of the following:
-
acute coronary syndrome (such as myocardial infarction or unstable angina needing hospitalisation)
-
coronary or other arterial revascularisation procedures
-
coronary heart disease
-
ischaemic stroke
-
peripheral arterial disease, and
-
-
low-density lipoprotein cholesterol (LDL‑C) levels above 1.04 mmol/litre and below or equal to 2.60 mmol/litre.
Recommendation
LSCMMG Recommendation:
Green (Restricted)
Reason for decision:
Suitable for initiation in primary care in line with restrictions